WithdrawnPhase 4ketamine
Alcohol Withdrawal Syndrome Treated With Adjunctive Phenobarbital or Ketamine
Sponsored by Santa Barbara Cottage Hospital
NCT ID
NCT03788889
Start Date
2019-04-12
Est. Completion
2019-04-12
About This Study
The goal of this study will aim to determine if adding phenobarbital or ketamine to a symptom-triggered benzodiazepine regimen decreases the rate of intensive care unit admissions during the treatment of alcohol withdrawal syndrome when compared to symptom-triggered benzodiazepine therapy alone.
Conditions Studied
Interventions
- •Ketamine
- •Phenobarbital
- •Lorazepam
- •Placebo A
- •Placebo B
Eligibility
Age:18 Years - N/A
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria: * Primary admitting diagnosis of acute alcohol withdrawal syndrome based on International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10), code F10.3, F10.4. Exclusion Criteria: * Significant comorbid medical illness requiring Intensive Care Unit admission; * Pregnancy; * Inability to obtain intravenous access; * Child Pugh Class C; and * Allergy to study medications (phenobarbital, ketamine, lorazepam).